TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 185 filers reported holding TG THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,976 | -99.2% | 197,884 | +197.8% | 0.04% | +600.0% |
Q3 2022 | $393,000 | +72.4% | 66,443 | +452.8% | 0.01% | +400.0% |
Q4 2021 | $228,000 | -68.7% | 12,020 | -45.1% | 0.00% | -66.7% |
Q3 2021 | $729,000 | +235.9% | 21,896 | +291.7% | 0.00% | +200.0% |
Q2 2021 | $217,000 | -79.2% | 5,590 | -74.1% | 0.00% | -80.0% |
Q1 2021 | $1,042,000 | +72.5% | 21,612 | +86.3% | 0.01% | +66.7% |
Q4 2020 | $604,000 | -57.0% | 11,603 | -77.9% | 0.00% | -66.7% |
Q3 2020 | $1,405,000 | +428.2% | 52,511 | +284.8% | 0.01% | +350.0% |
Q2 2020 | $266,000 | +60.2% | 13,645 | -19.0% | 0.00% | 0.0% |
Q1 2020 | $166,000 | +8.5% | 16,853 | -38.2% | 0.00% | +100.0% |
Q3 2019 | $153,000 | -42.7% | 27,266 | -11.6% | 0.00% | -50.0% |
Q2 2019 | $267,000 | +13.1% | 30,858 | +5.0% | 0.00% | 0.0% |
Q1 2019 | $236,000 | +50.3% | 29,377 | -23.3% | 0.00% | +100.0% |
Q4 2018 | $157,000 | +86.9% | 38,285 | +154.9% | 0.00% | 0.0% |
Q3 2018 | $84,000 | -22.9% | 15,022 | +117.6% | 0.00% | 0.0% |
Q4 2014 | $109,000 | – | 6,905 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
Antara Capital LP | 900,000 | $3,825,000 | 0.16% |